A RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY VIR-7831 FOR THE EARLY TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) IN NON-HOSPITALIZED PATIENTS

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2021
This article has no abstract
Epistemonikos ID: 722042680c53708b420c5f4798ce054e247eca3a
First added on: Jul 08, 2021